about
Exicure Inc is a clinical-stage biotechnology company focused on developing treatments for blood-related diseases, with an emphasis on small-molecule therapies that have the potential to benefit a broad range of patients. The company acquired GPCR Th...
Read More
1.24
-0.02
(-1.59%)
13,440.9
XNAS Volume
XNAS 22 Sep, 2026 2:33 PM (EDT)
Not Eligible
Expensive Valuation
Technically Bearish
Exicure Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..